TÁC ĐỘNG KÌM HÃM SỰ DI TRÚ VÀ XÂM LẤN ĐỐI VỚI TẾ BÀO UNG THƯ GAN CỦA DỊCH CHIẾT ETHANOL TỪ CÂY AMPELOPSIS CANTONIENSIS TRÊN MÔ HÌNH NUÔI CẤY 2D VÀ 3D
Thông tin bài báo
Ngày nhận bài: 20/05/24                Ngày hoàn thiện: 17/06/24                Ngày đăng: 17/06/24Tóm tắt
Từ khóa
Toàn văn:
PDFTài liệu tham khảo
[1] A. Marengo, C. Rosso, and E. Bugianesi, “Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis,” Annu. Rev. Med., vol. 67, no. 1, pp. 103-117, 2016, doi: 10.1146/annurev-med-090514-013832.
[2] J. M. Llovet et al., “Hepatocellular carcinoma,” Nat. Rev. Dis. Primer, vol. 7, no. 1, pp. 1-28, 2021, doi: 10.1038/s41572-020-00240-3.
[3] F. Bray et al., “Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA. Cancer J. Clin., vol. 74, no. 3, 2024, doi: 10.3322/caac.21834.
[4] J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: An update,” Hepatology, vol. 53, no. 3, pp. 1020-1022, 2011, doi: 10.1002/hep.24199.
[5] R. R. Love, H. Leventhal, D. V. Easterling, and D. R. Nerenz, “Side effects and emotional distress during cancer chemotherapy,” Cancer, vol. 63, no. 3, pp. 604-612, 1989, doi: 10.1002/1097-0142(19890201)63:3<604:aid-cncr2820630334>3.0.co;2-2.
[6] V. Dilalla, G. Chaput, T. Williams, and K. Sultanem, “Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients,” Curr. Oncol., vol. 27, no. 2, pp. 107-112, 2020, doi: 10.3747/co.27.6233.
[7] A. B. El-Khoueiry et al., “Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial,” The Lancet, vol. 389, no. 10088, pp. 2492-2502, 2017, doi: 10.1016/s0140-6736(17)31046-2.
[8] V. Schirrmacher, “From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review),” Int. J. Oncol., vol. 54, no. 2, pp. 407-419, 2017, doi: 10.3892/ijo.2018.4661.
[9] A. Bozorgi, S. Khazaei, A. Khademi, and M. Khazaei, “Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells,” PubMed, vol. 23, no. 8, pp. 970-983, 2020, doi: 10.22038/ijbms.2020.43745.10270.
[10] A. Ranjan et al., “Role of Phytochemicals in Cancer Prevention,” Int. J. Mol. Sci., vol. 20, no. 20, 2019, doi: 10.3390/ijms20204981.
[11] Y. Liu et al., “Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products,” Cell Prolif., vol. 53, no. 10, p. e12894, 2020, doi: 10.1111/cpr.12894.
[12] T. B. Nguyen, List of Plant Species in Vietnam. Agriculture Publishing House, 2005.
[13] X. Song et al., “Myricetin: A review of the most recent research,” Biomed. Pharmacother, vol. 134, p. 111017, 2021, doi: 10.1016/j.biopha.2020.111017.
[14] Y. Liu et al., “Anticancer and antibacterial flavonoids from the callus of Ampelopsis grossedentata; a new weapon to mitigate the proliferation of cancer cells and bacteria,” RSC Adv., vol. 12, no. 37, pp. 24130-24138, 2022, doi: 10.1039/d2ra03437a.
[15] T. Su et al., “An Ethanolic Extract of Ampelopsis Radix Exerts Anti-colorectal Cancer Effects and Potently Inhibits STAT3 Signaling In Vitro,” Front. Pharmacol., vol. 8, 2017, doi: 10.3389/fphar.2017.00227.
[16] K. J. Nho, J. M. Chun, D.-S. Kim, and H. K. Kim, “Ampelopsis japonica ethanol extract suppresses migration and invasion in human MDA-MB-231 breast cancer cells,” Mol. Med. Rep., vol. 11, no. 5, pp. 3722-3728, 2015, doi: 10.3892/mmr.2015.3179.
[17] V. N. T. Bich et al., “Investigating the antibacterial mechanism of Ampelopsis cantoniensis extracts against methicillin-resistant Staphylococcus aureus via in vitro and in silico analysis,” J. Biomol. Struct. Dyn., vol. 41, no. 23, pp. 14080–14091, Dec. 2023, doi: 10.1080/07391102.2023.2187218.
[18] N. V. Thu et al., “Anti-inflammatory compounds from Ampelopsis cantoniensis,” Nat. Prod. Commun., vol. 10, no. 3, pp. 383-385, 2015.
[19] L. Ciumărnean et al., “The Effects of Flavonoids in Cardiovascular Diseases,” Molecules, vol. 25, no. 18, p. 4320, 2020, doi: 10.3390/molecules25184320.
[20] S. Lalani and C. L. Poh, “Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71),” Viruses, vol. 12, no. 2, p. 184, 2020, doi: 10.3390/v12020184.
[21] C. R. Ferraz et al., “Therapeutic Potential of Flavonoids in Pain and Inflammation: Mechanisms of Action, Pre-Clinical and Clinical Data, and Pharmaceutical Development,” Molecules, vol. 25, no. 3, p. 762, 2020, doi: 10.3390/molecules25030762.
[22] N. T. Nguyen, Methods of Plant Research. Hanoi National University, 2007.
[23] Institute of Medical Materials, List of Vietnamese medicinal plants. Ha Noi: Science and Technology Publishing House, 2016.
[24] J. Yang et al., “Guidelines and definitions for research on epithelial–mesenchymal transition,” Nat. Rev. Mol. Cell Biol., vol. 21, no. 6, pp. 341-352, 2020, doi: 10.1038/s41580-020-0237-9.
[25] A. Barrallo-Gimeno, “The Snail genes as inducers of cell movement and survival: implications in development and cancer,” Development, vol. 132, no. 14, pp. 3151-3161, 2005, doi: 10.1242/dev.01907.
[26] P. K. Yadav, M. Ghosh, and M. Kataria, “Matrix Metalloproteinases (MMPs) in Cancer Immunotherapy,” Springer EBooks, pp. 1-26, 2022, doi: 10.1007/978-981-16-1247-3_182-1.
[27] Q.-Y. Zhang et al., “Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression,” World J. Gastroenterol., vol. 20, no. 29, p. 10082, 2014, doi: 10.3748/wjg.v20.i29.10082.
[28] Y. Zhao, X. Liu, C. Ding, Y. Gu, and W. Liu, “Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway,” Front. Pharmacol., vol. 12, 2021, doi: 10.3389/fphar.2021.783886.
[29] X. Zhou et al., “Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways,” Hepatol. Res., vol. 42, no. 4, pp. 401-411, 2011, doi: 10.1111/j.1872-034x.2011.00933.x.
[30] Y. Wang et al., “MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor,” BMC Cancer, vol. 23, no. 1, 2023, doi: 10.1186/s12885-023-11480-11483.
[31] M. Kciuk, A. Gielecińska, A. Budzinska, M. Mojzych, and R. Kontek, “Metastasis and MAPK Pathways,” Int. J. Mol. Sci., vol. 23, no. 7, p. 3847, 2022, doi: 10.3390/ijms23073847.
[32] K. B. Reddy, S. M. Nabha, and N. Atanaskova, “Role of MAP kinase in tumor progression and invasion,” Cancer Metastasis Rev., vol. 22, no. 4, pp. 395-403, 2003, doi: 10.1023/a:1023781114568.DOI: https://doi.org/10.34238/tnu-jst.10423
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu